NSRX Insider Trading Activity and SEC Form 4 Filings
NSRX insider trading summary
Over the past 12 months, insiders at Nasus Pharma Ltd (NSRX) reported 3 open-market purchases worth $62K by 1 insider and no sales on SEC Form 4. Net insider buying was $62K.
Latest NSRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Dan Benjamin Teleman | Chief Executive Officer | Buy | $20K (6,550 @ $3.10) |
| Apr 22, 2026 | Dan Benjamin Teleman | Chief Executive Officer | Buy | $11K (2,900 @ $3.76) |
| Mar 31, 2026 | Dan Benjamin Teleman | Chief Executive Officer | Buy | $31K (15,000 @ $2.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.